CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

VRXAVeraxa Biotech AG

NASDAQ · Pharmaceutical Preparations
Last close $1.25 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-29 · Hosseinion Warren (Director) · BUY
  • 2026-08-31 · Baumann Oliver Rolf (Director) · BUY
  • 2026-08-31 · Antz Christoph Rudiger (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders30
Shares held9,370,250
Value$1.56M
As of quarter end2026-06-30
RECENT NEWS
  • VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Veraxa Biotech AG (VRXA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit